Advertisement
U.S. markets open in 1 hour 39 minutes

Agile Therapeutics, Inc. (AGRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.5600+0.0170 (+3.13%)
At close: 04:00PM EDT
0.5814 +0.02 (+3.82%)
Pre-Market: 07:21AM EDT
Advertisement
Show:
Annual
Subscribe to Yahoo Finance Plus Essential to download historical data

Income Statement

All numbers in thousands
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.
Breakdown
ttm
12/31/2022
12/31/2021
12/31/2020
Total Revenue
19,975
10,884
4,101
749
Cost of Revenue
8,440
6,836
10,718
282
Gross Profit
11,535
4,048
-6,617
467
Operating Expense
34,245
45,482
64,388
49,520
Operating Income
-22,710
-41,434
-71,005
-49,053
Net Non Operating Interest Income Expense
-1,455
-3,051
-3,889
-2,800
Other Income Expense
10,239
14,398
3,827
-
Pretax Income
-13,926
-30,087
-71,067
-51,853
Tax Provision
0
-4,675
0
0
Net Income Common Stockholders
-13,926
-25,412
-71,067
-51,853
Diluted NI Available to Com Stockholders
-13,926
-25,412
-71,067
-51,853
Basic EPS
7.31
-59.00
-1.54k
-1.22k
Diluted EPS
7.31
-59.00
-1.54k
-1.22k
Basic Average Shares
1,621
432.218
48.536
42.341
Diluted Average Shares
1,621
432.218
48.536
42.341
Total Operating Income as Reported
-22,710
-52,556
-71,005
-49,053
Total Expenses
42,685
52,318
75,106
49,802
Net Income from Continuing & Discontinued Operation
-13,926
-25,412
-71,067
-51,853
Normalized Income
-24,165
-37,521
-74,894
-51,853
Interest Income
91
80
25
309
Interest Expense
1,546
3,131
3,914
3,109
Net Interest Income
-1,455
-3,051
-3,889
-2,800
EBIT
-12,380
-26,956
-67,153
-48,744
EBITDA
-12,003
-25,422
-64,930
-48,468
Reconciled Cost of Revenue
8,440
6,836
10,718
282
Reconciled Depreciation
377
1,534
2,223
276
Net Income from Continuing Operation Net Minority Interest
-13,926
-25,412
-71,067
-51,853
Total Unusual Items Excluding Goodwill
10,239
14,398
3,827
0
Total Unusual Items
10,239
14,398
3,827
0
Normalized EBITDA
-22,242
-39,820
-68,757
-48,468
Tax Rate for Calcs
0
0
0
0
Tax Effect of Unusual Items
0
2,289
0
0